rs144605615

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001278116.2(L1CAM):​c.28C>T​(p.Pro10Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00163 in 1,208,295 control chromosomes in the GnomAD database, including 18 homozygotes. There are 492 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P10P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0089 ( 10 hom., 238 hem., cov: 23)
Exomes 𝑓: 0.00089 ( 8 hom. 254 hem. )

Consequence

L1CAM
NM_001278116.2 missense

Scores

4
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.56

Publications

3 publications found
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
L1CAM Gene-Disease associations (from GenCC):
  • L1 syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • MASA syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • X-linked complicated corpus callosum dysgenesis
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • X-linked complicated spastic paraplegia type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008834422).
BP6
Variant X-153875809-G-A is Benign according to our data. Variant chrX-153875809-G-A is described in ClinVar as [Benign]. Clinvar id is 92930.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00892 (995/111555) while in subpopulation AFR AF = 0.0312 (955/30653). AF 95% confidence interval is 0.0295. There are 10 homozygotes in GnomAd4. There are 238 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
L1CAMNM_001278116.2 linkc.28C>T p.Pro10Ser missense_variant Exon 2 of 29 ENST00000370060.7 NP_001265045.1 P32004-1
L1CAMNM_000425.5 linkc.28C>T p.Pro10Ser missense_variant Exon 1 of 28 NP_000416.1 P32004-1
L1CAMNM_024003.3 linkc.28C>T p.Pro10Ser missense_variant Exon 1 of 27 NP_076493.1 P32004-2
L1CAMNM_001143963.2 linkc.28C>T p.Pro10Ser missense_variant Exon 1 of 26 NP_001137435.1 P32004-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
L1CAMENST00000370060.7 linkc.28C>T p.Pro10Ser missense_variant Exon 2 of 29 5 NM_001278116.2 ENSP00000359077.1 P32004-1
ENSG00000284987ENST00000646191.1 linkn.*70C>T non_coding_transcript_exon_variant Exon 2 of 5 ENSP00000493873.1 A0A2R8Y4P6
ENSG00000284987ENST00000646191.1 linkn.*70C>T 3_prime_UTR_variant Exon 2 of 5 ENSP00000493873.1 A0A2R8Y4P6

Frequencies

GnomAD3 genomes
AF:
0.00891
AC:
993
AN:
111504
Hom.:
10
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0312
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00244
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0125
Gnomad NFE
AF:
0.0000378
Gnomad OTH
AF:
0.00597
GnomAD2 exomes
AF:
0.00261
AC:
473
AN:
180985
AF XY:
0.00151
show subpopulations
Gnomad AFR exome
AF:
0.0337
Gnomad AMR exome
AF:
0.000987
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00111
GnomAD4 exome
AF:
0.000894
AC:
980
AN:
1096740
Hom.:
8
Cov.:
31
AF XY:
0.000701
AC XY:
254
AN XY:
362462
show subpopulations
African (AFR)
AF:
0.0323
AC:
853
AN:
26383
American (AMR)
AF:
0.00111
AC:
39
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54106
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39782
Middle Eastern (MID)
AF:
0.00132
AC:
5
AN:
3777
European-Non Finnish (NFE)
AF:
0.0000131
AC:
11
AN:
841878
Other (OTH)
AF:
0.00156
AC:
72
AN:
46026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
48
96
144
192
240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00892
AC:
995
AN:
111555
Hom.:
10
Cov.:
23
AF XY:
0.00705
AC XY:
238
AN XY:
33777
show subpopulations
African (AFR)
AF:
0.0312
AC:
955
AN:
30653
American (AMR)
AF:
0.00244
AC:
26
AN:
10649
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2637
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3522
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2662
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6107
Middle Eastern (MID)
AF:
0.0137
AC:
3
AN:
219
European-Non Finnish (NFE)
AF:
0.0000378
AC:
2
AN:
52901
Other (OTH)
AF:
0.00589
AC:
9
AN:
1527
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00231
Hom.:
71
Bravo
AF:
0.0104
ESP6500AA
AF:
0.0321
AC:
123
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00282
AC:
342

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 30, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 23, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Aug 01, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 14, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Dec 24, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.35
.;T;.;.;T;T;T;T
FATHMM_MKL
Benign
0.015
N
LIST_S2
Uncertain
0.90
D;D;.;D;D;D;D;D
MetaRNN
Benign
0.0088
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N;N;N;.;.;.;.
PhyloP100
1.6
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
0.42
N;N;N;N;N;N;N;N
REVEL
Benign
0.096
Sift
Uncertain
0.010
D;D;D;D;T;T;T;D
Sift4G
Benign
0.53
T;T;T;T;.;.;D;.
Polyphen
0.046, 0.0090
.;B;.;B;.;.;.;.
Vest4
0.27
MVP
0.63
MPC
0.55
ClinPred
0.018
T
GERP RS
2.7
PromoterAI
-0.19
Neutral
Varity_R
0.081
gMVP
0.56
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144605615; hg19: chrX-153141264; COSMIC: COSV99051951; COSMIC: COSV99051951; API